Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon
Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits composed of residues 3−9 (heptapeptide 15), pentadepsipeptide 26 (residues 1, 2 and 15−17), and pentapeptide 34 (residues 10−14) were prepared, sequentially coupled, and cycliz...
Gespeichert in:
Veröffentlicht in: | Journal of the American Chemical Society 2003-02, Vol.125 (7), p.1877-1887 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1887 |
---|---|
container_issue | 7 |
container_start_page | 1877 |
container_title | Journal of the American Chemical Society |
container_volume | 125 |
creator | Jiang, Wanlong Wanner, Jutta Lee, Richard J Bounaud, Pierre-Yves Boger, Dale L |
description | Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits composed of residues 3−9 (heptapeptide 15), pentadepsipeptide 26 (residues 1, 2 and 15−17), and pentapeptide 34 (residues 10−14) were prepared, sequentially coupled, and cyclized to provide the 49-membered depsipeptide core of the aglycon. Key to the preparation of the pentadepsipeptide 26 incorporating the backbone ester was the asymmetric synthesis of an orthogonally protected l-threo-β-hydroxyasparagine and the development of effective and near-racemization free conditions for esterification of its hindered alcohol (EDCI, DMAP, 0 °C). The coupling sites were chosen to maximize the convergency of the synthesis including that of the three subunits, to prevent late stage racemization of carboxylate-activated phenylglycine-derived residues, and to enlist β-sheet preorganization of an acyclic macrocyclization substrate for 49-membered ring closure. By altering the order of final couplings, two macrocyclization sites, Phe9−d-Orn10 and Gly14−Leu15, were examined. Macrocyclization at the highly successful Phe9−d-Orn10 site (89%) may benefit from both β-sheet preorganization as well as closure at a d-amine terminus within the confines of a β-turn at the end of the H-bonded antiparallel β-strands. A more modest, but acceptable macrocyclization reaction at the Gly14−Leu15 site (40−50%) found at the other end of the H-bonded antiparallel β-strands within a small flexible loop may also benefit from preorganization of the cyclization substrate, is conducted on a substrate incapable of competitive racemization, and accommodates the convergent preparation of analogues bearing depsipeptide modifications. Deliberate late-stage incorporation of the subunit bearing the labile depsipeptide ester and a final stage Asn1 side-chain introduction provides future access to analogues of the aglycons which themselves are equally potent or more potent than the natural products in antimicrobial assays. |
doi_str_mv | 10.1021/ja0212314 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73019686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73019686</sourcerecordid><originalsourceid>FETCH-LOGICAL-a480t-3c4c76da64ff5de4a9e7ec66c33980b8dd10d320dac2435b3685757b13b60fb03</originalsourceid><addsrcrecordid>eNptkE9LAzEQxYMotlYPfgHZi4KH1fxPCl5q0SoIiq3iLWSzWd26u6nJLthvb0pLe_GSycz8eLx5AJwieIUgRtdzHV9MEN0DfcQwTBnCfB_0IYQ4FZKTHjgKYR5biiU6BD2EmYQcsT64mblWV8l02bRfNpQhcUUSf8mrrt2i0k3ZJCOc6CbfTlywyeizWhrXHIODQlfBnmzqALzd383GD-nT8-RxPHpKNZWwTYmhRvBcc1oULLdUD62whnNDyFDCTOY5gjnBMNcGU8IywiUTTGSIZBwWGSQDcLHWXXj309nQqroMxlbRjXVdUIJANOTxzgG4XIPGuxC8LdTCl7X2S4WgWkWltlFF9mwj2mW1zXfkJpsInG8AHYyuCq8bU4YdRxmXiK7cpWuuDK393e61_1ZcEMHU7GWqxpy-335MiOI7XW2CmrvONzG7fwz-AefdiT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73019686</pqid></control><display><type>article</type><title>Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon</title><source>MEDLINE</source><source>ACS Publications</source><creator>Jiang, Wanlong ; Wanner, Jutta ; Lee, Richard J ; Bounaud, Pierre-Yves ; Boger, Dale L</creator><creatorcontrib>Jiang, Wanlong ; Wanner, Jutta ; Lee, Richard J ; Bounaud, Pierre-Yves ; Boger, Dale L</creatorcontrib><description>Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits composed of residues 3−9 (heptapeptide 15), pentadepsipeptide 26 (residues 1, 2 and 15−17), and pentapeptide 34 (residues 10−14) were prepared, sequentially coupled, and cyclized to provide the 49-membered depsipeptide core of the aglycon. Key to the preparation of the pentadepsipeptide 26 incorporating the backbone ester was the asymmetric synthesis of an orthogonally protected l-threo-β-hydroxyasparagine and the development of effective and near-racemization free conditions for esterification of its hindered alcohol (EDCI, DMAP, 0 °C). The coupling sites were chosen to maximize the convergency of the synthesis including that of the three subunits, to prevent late stage racemization of carboxylate-activated phenylglycine-derived residues, and to enlist β-sheet preorganization of an acyclic macrocyclization substrate for 49-membered ring closure. By altering the order of final couplings, two macrocyclization sites, Phe9−d-Orn10 and Gly14−Leu15, were examined. Macrocyclization at the highly successful Phe9−d-Orn10 site (89%) may benefit from both β-sheet preorganization as well as closure at a d-amine terminus within the confines of a β-turn at the end of the H-bonded antiparallel β-strands. A more modest, but acceptable macrocyclization reaction at the Gly14−Leu15 site (40−50%) found at the other end of the H-bonded antiparallel β-strands within a small flexible loop may also benefit from preorganization of the cyclization substrate, is conducted on a substrate incapable of competitive racemization, and accommodates the convergent preparation of analogues bearing depsipeptide modifications. Deliberate late-stage incorporation of the subunit bearing the labile depsipeptide ester and a final stage Asn1 side-chain introduction provides future access to analogues of the aglycons which themselves are equally potent or more potent than the natural products in antimicrobial assays.</description><identifier>ISSN: 0002-7863</identifier><identifier>EISSN: 1520-5126</identifier><identifier>DOI: 10.1021/ja0212314</identifier><identifier>PMID: 12580615</identifier><identifier>CODEN: JACSAT</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Anti-Bacterial Agents - chemical synthesis ; Anti-Bacterial Agents - chemistry ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Chemistry ; Depsipeptides ; Exact sciences and technology ; Glycoproteins - chemical synthesis ; Glycoproteins - chemistry ; Medical sciences ; Models, Molecular ; Oligopeptides - chemical synthesis ; Oligopeptides - chemistry ; Organic chemistry ; Peptides ; Peptides, Cyclic - chemical synthesis ; Peptides, Cyclic - chemistry ; Pharmacology. Drug treatments ; Preparations and properties ; Protein Structure, Secondary</subject><ispartof>Journal of the American Chemical Society, 2003-02, Vol.125 (7), p.1877-1887</ispartof><rights>Copyright © 2003 American Chemical Society</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a480t-3c4c76da64ff5de4a9e7ec66c33980b8dd10d320dac2435b3685757b13b60fb03</citedby><cites>FETCH-LOGICAL-a480t-3c4c76da64ff5de4a9e7ec66c33980b8dd10d320dac2435b3685757b13b60fb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ja0212314$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ja0212314$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27074,27922,27923,56736,56786</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14568140$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12580615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Wanlong</creatorcontrib><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Lee, Richard J</creatorcontrib><creatorcontrib>Bounaud, Pierre-Yves</creatorcontrib><creatorcontrib>Boger, Dale L</creatorcontrib><title>Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon</title><title>Journal of the American Chemical Society</title><addtitle>J. Am. Chem. Soc</addtitle><description>Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits composed of residues 3−9 (heptapeptide 15), pentadepsipeptide 26 (residues 1, 2 and 15−17), and pentapeptide 34 (residues 10−14) were prepared, sequentially coupled, and cyclized to provide the 49-membered depsipeptide core of the aglycon. Key to the preparation of the pentadepsipeptide 26 incorporating the backbone ester was the asymmetric synthesis of an orthogonally protected l-threo-β-hydroxyasparagine and the development of effective and near-racemization free conditions for esterification of its hindered alcohol (EDCI, DMAP, 0 °C). The coupling sites were chosen to maximize the convergency of the synthesis including that of the three subunits, to prevent late stage racemization of carboxylate-activated phenylglycine-derived residues, and to enlist β-sheet preorganization of an acyclic macrocyclization substrate for 49-membered ring closure. By altering the order of final couplings, two macrocyclization sites, Phe9−d-Orn10 and Gly14−Leu15, were examined. Macrocyclization at the highly successful Phe9−d-Orn10 site (89%) may benefit from both β-sheet preorganization as well as closure at a d-amine terminus within the confines of a β-turn at the end of the H-bonded antiparallel β-strands. A more modest, but acceptable macrocyclization reaction at the Gly14−Leu15 site (40−50%) found at the other end of the H-bonded antiparallel β-strands within a small flexible loop may also benefit from preorganization of the cyclization substrate, is conducted on a substrate incapable of competitive racemization, and accommodates the convergent preparation of analogues bearing depsipeptide modifications. Deliberate late-stage incorporation of the subunit bearing the labile depsipeptide ester and a final stage Asn1 side-chain introduction provides future access to analogues of the aglycons which themselves are equally potent or more potent than the natural products in antimicrobial assays.</description><subject>Anti-Bacterial Agents - chemical synthesis</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Chemistry</subject><subject>Depsipeptides</subject><subject>Exact sciences and technology</subject><subject>Glycoproteins - chemical synthesis</subject><subject>Glycoproteins - chemistry</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Oligopeptides - chemical synthesis</subject><subject>Oligopeptides - chemistry</subject><subject>Organic chemistry</subject><subject>Peptides</subject><subject>Peptides, Cyclic - chemical synthesis</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Pharmacology. Drug treatments</subject><subject>Preparations and properties</subject><subject>Protein Structure, Secondary</subject><issn>0002-7863</issn><issn>1520-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE9LAzEQxYMotlYPfgHZi4KH1fxPCl5q0SoIiq3iLWSzWd26u6nJLthvb0pLe_GSycz8eLx5AJwieIUgRtdzHV9MEN0DfcQwTBnCfB_0IYQ4FZKTHjgKYR5biiU6BD2EmYQcsT64mblWV8l02bRfNpQhcUUSf8mrrt2i0k3ZJCOc6CbfTlywyeizWhrXHIODQlfBnmzqALzd383GD-nT8-RxPHpKNZWwTYmhRvBcc1oULLdUD62whnNDyFDCTOY5gjnBMNcGU8IywiUTTGSIZBwWGSQDcLHWXXj309nQqroMxlbRjXVdUIJANOTxzgG4XIPGuxC8LdTCl7X2S4WgWkWltlFF9mwj2mW1zXfkJpsInG8AHYyuCq8bU4YdRxmXiK7cpWuuDK393e61_1ZcEMHU7GWqxpy-335MiOI7XW2CmrvONzG7fwz-AefdiT0</recordid><startdate>20030219</startdate><enddate>20030219</enddate><creator>Jiang, Wanlong</creator><creator>Wanner, Jutta</creator><creator>Lee, Richard J</creator><creator>Bounaud, Pierre-Yves</creator><creator>Boger, Dale L</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030219</creationdate><title>Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon</title><author>Jiang, Wanlong ; Wanner, Jutta ; Lee, Richard J ; Bounaud, Pierre-Yves ; Boger, Dale L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a480t-3c4c76da64ff5de4a9e7ec66c33980b8dd10d320dac2435b3685757b13b60fb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anti-Bacterial Agents - chemical synthesis</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Chemistry</topic><topic>Depsipeptides</topic><topic>Exact sciences and technology</topic><topic>Glycoproteins - chemical synthesis</topic><topic>Glycoproteins - chemistry</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Oligopeptides - chemical synthesis</topic><topic>Oligopeptides - chemistry</topic><topic>Organic chemistry</topic><topic>Peptides</topic><topic>Peptides, Cyclic - chemical synthesis</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Pharmacology. Drug treatments</topic><topic>Preparations and properties</topic><topic>Protein Structure, Secondary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Wanlong</creatorcontrib><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Lee, Richard J</creatorcontrib><creatorcontrib>Bounaud, Pierre-Yves</creatorcontrib><creatorcontrib>Boger, Dale L</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Chemical Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Wanlong</au><au>Wanner, Jutta</au><au>Lee, Richard J</au><au>Bounaud, Pierre-Yves</au><au>Boger, Dale L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon</atitle><jtitle>Journal of the American Chemical Society</jtitle><addtitle>J. Am. Chem. Soc</addtitle><date>2003-02-19</date><risdate>2003</risdate><volume>125</volume><issue>7</issue><spage>1877</spage><epage>1887</epage><pages>1877-1887</pages><issn>0002-7863</issn><eissn>1520-5126</eissn><coden>JACSAT</coden><abstract>Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits composed of residues 3−9 (heptapeptide 15), pentadepsipeptide 26 (residues 1, 2 and 15−17), and pentapeptide 34 (residues 10−14) were prepared, sequentially coupled, and cyclized to provide the 49-membered depsipeptide core of the aglycon. Key to the preparation of the pentadepsipeptide 26 incorporating the backbone ester was the asymmetric synthesis of an orthogonally protected l-threo-β-hydroxyasparagine and the development of effective and near-racemization free conditions for esterification of its hindered alcohol (EDCI, DMAP, 0 °C). The coupling sites were chosen to maximize the convergency of the synthesis including that of the three subunits, to prevent late stage racemization of carboxylate-activated phenylglycine-derived residues, and to enlist β-sheet preorganization of an acyclic macrocyclization substrate for 49-membered ring closure. By altering the order of final couplings, two macrocyclization sites, Phe9−d-Orn10 and Gly14−Leu15, were examined. Macrocyclization at the highly successful Phe9−d-Orn10 site (89%) may benefit from both β-sheet preorganization as well as closure at a d-amine terminus within the confines of a β-turn at the end of the H-bonded antiparallel β-strands. A more modest, but acceptable macrocyclization reaction at the Gly14−Leu15 site (40−50%) found at the other end of the H-bonded antiparallel β-strands within a small flexible loop may also benefit from preorganization of the cyclization substrate, is conducted on a substrate incapable of competitive racemization, and accommodates the convergent preparation of analogues bearing depsipeptide modifications. Deliberate late-stage incorporation of the subunit bearing the labile depsipeptide ester and a final stage Asn1 side-chain introduction provides future access to analogues of the aglycons which themselves are equally potent or more potent than the natural products in antimicrobial assays.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>12580615</pmid><doi>10.1021/ja0212314</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-7863 |
ispartof | Journal of the American Chemical Society, 2003-02, Vol.125 (7), p.1877-1887 |
issn | 0002-7863 1520-5126 |
language | eng |
recordid | cdi_proquest_miscellaneous_73019686 |
source | MEDLINE; ACS Publications |
subjects | Anti-Bacterial Agents - chemical synthesis Anti-Bacterial Agents - chemistry Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Chemistry Depsipeptides Exact sciences and technology Glycoproteins - chemical synthesis Glycoproteins - chemistry Medical sciences Models, Molecular Oligopeptides - chemical synthesis Oligopeptides - chemistry Organic chemistry Peptides Peptides, Cyclic - chemical synthesis Peptides, Cyclic - chemistry Pharmacology. Drug treatments Preparations and properties Protein Structure, Secondary |
title | Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A23%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20Synthesis%20of%20the%20Ramoplanin%20A2%20and%20Ramoplanose%20Aglycon&rft.jtitle=Journal%20of%20the%20American%20Chemical%20Society&rft.au=Jiang,%20Wanlong&rft.date=2003-02-19&rft.volume=125&rft.issue=7&rft.spage=1877&rft.epage=1887&rft.pages=1877-1887&rft.issn=0002-7863&rft.eissn=1520-5126&rft.coden=JACSAT&rft_id=info:doi/10.1021/ja0212314&rft_dat=%3Cproquest_cross%3E73019686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73019686&rft_id=info:pmid/12580615&rfr_iscdi=true |